ACCRU Clinical Trials
The common characteristic of all the ACCRU clinical trials is innovation. We aspire to change the standard of care for patients in all the major disease groups, improving and extending their lives. Our investigators, community doctors, and industry sponsors – every ACCRU member – are united in this mission.
ACCRU’s membership comprises investigators and community doctors from across the major disease groups. This includes Breast, Gastrointestinal, Genitourinary, Lung, Lymphoma, Myeloma, Symptom Control, and others. We aspire to grow our membership, expanding our clinical trial footprint to every major disease group.
ACCRU conducts industry-sponsored and investigator-initiated cancer treatment and symptom management trials across many types of cancer. This feature highlights one of ACCRU’s recent or current innovative trials.
Join in Our Mission
Interested in becoming a member of ACCRU?
Contact us to learn more about the value of ACCRU and the process of becoming a member.SIGN UP
Stories of Innovation and Collaboration.
Each month ACCRU’s podcast explores the people and ideas of today’s leading translational research. Hear the stories behind the innovative ideas and listen to the unique journeys of our researchers.SUBSCRIBE